Welcome to the 6th IPF Summit

From Repairing and Regenerating Lung Tissue to Illuminating Innovative Clinical Trial Design & Advance Scientific Progress; This is Your One-Stop-Shop to Supercharge IPF Research & Drug Development 

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2023 event, please get in touch at info@hansonwade.com

With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.  

Packed with 4 days of insightful content, the IPF Summit is back in Boston to help you delve into the persistent translational and clinical challenges in the space.  

This industry’s undisputed forum will unite 150+ industry giants and pioneering academics in-person including Boehringer Ingelheim, Genentech, Novartis, AbbVie, Gilead, Fernando Martinez, Naftali Kaminski, Toby Maher, and many more. Join them to gain end-to-end insights to empower you with the knowledge you need for your 2022/2023 IPF research and drug development goals.  

Organizations across autoimmunity, regenerative medicine, and inflammation are turning towards IPF as a strategic opportunity. Attend this dynamic meeting filled with formal presentations, interactive workshops, panel discussions, and organized networking to fast track your understanding, strategize success, and advance the IPF drug development frontier.

To learn more about the 2022 agenda and expert speaker faculty:

Your 50 Expert Speakers Included:

Fernando Martinez

Chief of the Pulmonary and Critical Care Medicine Division

Weill Cornell Medical College

Hana Cernecka

Head of Inflammation


Matthew Thomas

Head of Immunology & Respiratory Diseases Research for Germany

Boehringer Ingelheim

Yasmina Bauer

Head of Clinical Biomarkers


Joyce Lee

Associate Professor

University of Colorado Denver

Larry Tsai

Global Head of Respiratory & Rheumatology Product Development


Mark Eisner

Chief Medical Officer


Peter Schafer

Vice President

Bristol Myers Squibb

2022 Partners:

Program Partner


Hosting Partner

Innovation Partner

Exhibition Partners

Other Events in The Series: